Key Findings:  The authors conclude that THC and CBD have shown neuroprotective properties with relevance to patients with AD and PD. However, the team also warns of potential adverse effects.
Type of Study:  Meta-analysis
Study Result:  Positive
Cannabinoids Studied:  Cannabidiol (CBD), Tetrahydrocannabinol (THC)
Phytocannabinoid Source:  Not Applicable
Form of Administration:  Not Applicable
Study Location(s):  Australia
Year of Pub:  2020